Dragonfly Therapeutics Patents – Insights & Stats (Updated 2023)

Dragonfly Therapeutics has a total of 683 patents globally, out of which 20 have been granted. Of these 683 patents, more than 87% patents are active. The United States of America and Japan is where Dragonfly Therapeutics has filed the maximum number of patents, followed by Singapore and Europe. Parallely, United States of America seems to be the main focused R&D centre and also is the origin country of Dragonfly Therapeutics.

Dragonfly Therapeutics was founded in 2016. Dragonfly Therapeutics is a clinical-stage biopharmaceutical business dedicated to discovering, developing, and commercializing therapeutics that harness the body’s immune system to provide patients innovative treatments. It has also successfully collaborated with Merck, AbbVie, Gilead and Bristol Myers Squibb across a wide range of disease categories.

Do read about some of the most popular patents of Dragonfly Therapeutics which have been covered by us in this article and also you can find Dragonfly Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Dragonfly Therapeutics patent portfolio.

How many patents does Dragonfly Therapeutics have?

Dragonfly Therapeutics has a total of 683 patents globally. These patents belong to 73 unique patent families. Out of 683 patents, 598 patents are active.

How Many Patents did Dragonfly Therapeutics File Every Year?

Dragonfly Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantDragonfly Therapeutics Applications FiledDragonfly Therapeutics Patents Granted
20232117
2022521
20211041
2020106
20191931
2018206

How many Dragonfly Therapeutics patents are Alive/Dead?

Worldwide Patents

Dragonfly Therapeutics Patent Portfolio

How Many Patents did Dragonfly Therapeutics File in Different Countries?

Dragonfly Therapeutics Worldwide Patent Filing

Countries in which Dragonfly Therapeutics Filed Patents

CountryPatent
Japan49
United States Of America49
Singapore45
Europe43
Canada41
China40
Korea (South)39
Israel38
Australia38
Mexico37
India36
Brazil34
South Africa34
Hong Kong (S.A.R.)30
Taiwan11
Chile11
Malaysia11
Saudi Arabia10
Peru10
Colombia8
New Zealand8
Argentina5
Eurasia4
Russia3
Italy2
Finland2
Denmark2
Norway2
Pakistan1
Austria1

Where are Research Centers of Dragonfly Therapeutics Patents Located?

R&D Centers of Dragonfly Therapeutics

10 Best Dragonfly Therapeutics Patents

CN110662555A is the most popular patent in the Dragonfly Therapeutics portfolio. It has received 10 citations so far from companies like Shanghai Luoqi Biomedical Technology, Innovent Biologics (Suzhou) and Gigagen.

Below is the list of 10 most cited patents of Dragonfly Therapeutics:

Publication NumberCitation Count
CN110662555A10
WO2018217799A19
WO2020033702A18
WO2019231920A18
WO2019195409A17
WO2019157332A17
US20200376034A16
WO2019051308A15
WO2018157147A15
CN111315778A4

What Percentage of Dragonfly Therapeutics US Patent Applications Were Granted?

Dragonfly Therapeutics (Excluding its subsidiaries) has filed 29 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.

Below are the key stats of Dragonfly Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Blue Oak Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Goodwin Procter Llp230%

List of Dragonfly Therapeutics Patents

Dragonfly Therapeutics PatentsTitle
US20230109801A1Compounds And Compositions For Treating Cns Disorders
US20230116114A1Compounds And Compositions For Treating Cns Disorders
EP4084795A1Compounds And Compositions For Treating Cns Disorders
EP4084797A1Compounds And Compositions For Treating Cns Disorders
CN114929235ACompounds And Compositions For Treating Cns Disorders
CN114929228ACompounds And Compositions For Treating Cns Disorders
CA3161867A1Compounds And Compositions For Treating Cns Disorders
CA3165217A1Compounds And Compositions For Treating Cns Disorders
AU2020417248A1Compounds And Compositions For Treating Cns Disorders
AU2020416203A1Compounds And Compositions For Treating Cns Disorders
JP2023509700ACompounds And Compositions For Treating Cns Disorders
JP2023509453ACompounds And Compositions For Treating Cns Failure
HK40082254ACompounds And Compositions For Treating Cns Disorders
HK40082232ACompounds And Compositions For Treating Cns Disorders
IN202217034823ACompounds And Compositions For Treating Cns Disorders
IN202217032225ACompounds And Compositions For Treating Cns Disorders
KR1020220123404ACompounds And Compositions For Treating Cns Disorders
KR1020220123406ACompounds And Compositions For Treating Cns Disorders
BR112022010021A2Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders
BR112022010641A2Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders
WO2022204150A1Compounds And Compositions For Treating Cns Disorders
WO2021138314A1Compounds And Compositions For Treating Cns Disorders
WO2021138315A1Compounds And Compositions For Treating Cns Disorders

What are Dragonfly Therapeutics key innovation segments?

What Technologies are Covered by Dragonfly Therapeutics?

The chart below distributes patents filed by Dragonfly Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Dragonfly Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Dragonfly Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Dragonfly Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.